Overview
SCIENTIFIC SCORE
Possibly Effective
Based on 3 Researches
7.7
USERS' SCORE
Good
Based on 10 Reviews
8.4
Supplement Facts
Serving Size: 2 Soft Gels
Amount Per Serving
%DV
Calories
20
Total Fat
2 g
3%
Total Omega-3s♢
690 mg
†
EPA (Eicosapentaenoic Acid)
330 mg
†
DHA (Docosahexaenoic Acid)
220 mg
†
Top Medical Research Studies
8
We conducted a double-blind randomized controlled trial to understand how prenatal supplementation of docosahexaenoic acid (DHA) might influence infant health, particularly concerning the common cold. Pregnant women were given either a daily dose of 400 mg of DHA or a placebo starting at 18 to 22 weeks of gestation until childbirth.
Caregivers then reported on their infants’ health at 1, 3, and 6 months, sharing details about common illness symptoms. We found that DHA supplementation appeared to reduce the number of colds at one month and also seemed to lessen the duration of various cold symptoms in infants. Specifically, infants in the DHA group experienced fewer cold symptoms and had shorter durations of cough and wheezing.
While the overall occurrence of specific illness symptoms was similar between the DHA and placebo groups, DHA did bring about noteworthy benefits. At 1 month, infants in the DHA group had a 26% shorter duration of cough and 30% shorter wheezing; however, they experienced a longer duration of rash.
Furthermore, by the time the infants reached 3 months, those whose mothers took DHA were ill for 14% less time overall. At 6 months, the DHA group showed significantly reduced durations of several illness indicators, although they did experience longer episodes of vomiting.
This study suggests that prenatal DHA not only seems to impact the occurrence of colds in children but may also play a role in the duration of symptoms over the first half-year of life.
Caregivers then reported on their infants’ health at 1, 3, and 6 months, sharing details about common illness symptoms. We found that DHA supplementation appeared to reduce the number of colds at one month and also seemed to lessen the duration of various cold symptoms in infants. Specifically, infants in the DHA group experienced fewer cold symptoms and had shorter durations of cough and wheezing.
While the overall occurrence of specific illness symptoms was similar between the DHA and placebo groups, DHA did bring about noteworthy benefits. At 1 month, infants in the DHA group had a 26% shorter duration of cough and 30% shorter wheezing; however, they experienced a longer duration of rash.
Furthermore, by the time the infants reached 3 months, those whose mothers took DHA were ill for 14% less time overall. At 6 months, the DHA group showed significantly reduced durations of several illness indicators, although they did experience longer episodes of vomiting.
This study suggests that prenatal DHA not only seems to impact the occurrence of colds in children but may also play a role in the duration of symptoms over the first half-year of life.
Read More
7
We examined the MITIGATE study, focusing on the effects of icosapent ethyl (IPE), a purified omega-3 fatty acid, in adults with cardiovascular disease at risk for viral upper respiratory infections.
With about 16,500 participants, this clinical trial compared IPE treatment against usual care. The goal was to see if IPE could lessen the severity and impact of viral infections over six months.
Unfortunately, there was no significant evidence found that IPE improved outcomes for upper respiratory infections in this group.
With about 16,500 participants, this clinical trial compared IPE treatment against usual care. The goal was to see if IPE could lessen the severity and impact of viral infections over six months.
Unfortunately, there was no significant evidence found that IPE improved outcomes for upper respiratory infections in this group.
Read More
8
We investigated whether feeding infants formula supplemented with docosahexaenoic acid (DHA) and arachidonic acid (ARA) could impact the development of allergies and respiratory illnesses until age three.
In a well-structured, randomized, double-blind study, we followed children who received either supplemented or nonsupplemented formulas during their first year of life. Our findings showed that those on the DHA/ARA formula had significantly lower chances of developing upper respiratory infections and common allergic diseases.
Notably, the DHA/ARA group experienced a delayed onset and reduced incidence of respiratory issues, indicating potential benefits of early nutrition on long-term health.
In a well-structured, randomized, double-blind study, we followed children who received either supplemented or nonsupplemented formulas during their first year of life. Our findings showed that those on the DHA/ARA formula had significantly lower chances of developing upper respiratory infections and common allergic diseases.
Notably, the DHA/ARA group experienced a delayed onset and reduced incidence of respiratory issues, indicating potential benefits of early nutrition on long-term health.
Read More
Most Useful Reviews
9
Cold-free winter
6 people found this helpful
I have been taking this product for months and it's the first time I've never had that horrible 'fishy' taste after swallowing the pills. I’ve remained cold and flu free during winter in New Zealand, and my hair, nails, and skin appear fantastic. I highly recommend this product to anyone.
Read More
9
No flu experience
I've used this product all year and have not fallen ill with a cold or flu for the first time! It’s a fantastic product, has no fishy after-taste, and keeps my hair and nails looking fantastic. I highly recommend it to everyone.
Read More
9
Immune support
The ingredients are natural and good for health. Everyone should take it, as Omega-3 is beneficial for lowering cholesterol, improving hair growth, and providing anti-inflammatory properties. It strengthens the immune system and helps reduce the common cold's severity.
Read More
Medical Researches
SCIENTIFIC SCORE
Possibly Effective
Based on 3 Researches
7.7
- All Researches
8
We investigated whether feeding infants formula supplemented with docosahexaenoic acid (DHA) and arachidonic acid (ARA) could impact the development of allergies and respiratory illnesses until age three.
In a well-structured, randomized, double-blind study, we followed children who received either supplemented or nonsupplemented formulas during their first year of life. Our findings showed that those on the DHA/ARA formula had significantly lower chances of developing upper respiratory infections and common allergic diseases.
Notably, the DHA/ARA group experienced a delayed onset and reduced incidence of respiratory issues, indicating potential benefits of early nutrition on long-term health.
In a well-structured, randomized, double-blind study, we followed children who received either supplemented or nonsupplemented formulas during their first year of life. Our findings showed that those on the DHA/ARA formula had significantly lower chances of developing upper respiratory infections and common allergic diseases.
Notably, the DHA/ARA group experienced a delayed onset and reduced incidence of respiratory issues, indicating potential benefits of early nutrition on long-term health.
Read More
8
We conducted a double-blind randomized controlled trial to understand how prenatal supplementation of docosahexaenoic acid (DHA) might influence infant health, particularly concerning the common cold. Pregnant women were given either a daily dose of 400 mg of DHA or a placebo starting at 18 to 22 weeks of gestation until childbirth.
Caregivers then reported on their infants’ health at 1, 3, and 6 months, sharing details about common illness symptoms. We found that DHA supplementation appeared to reduce the number of colds at one month and also seemed to lessen the duration of various cold symptoms in infants. Specifically, infants in the DHA group experienced fewer cold symptoms and had shorter durations of cough and wheezing.
While the overall occurrence of specific illness symptoms was similar between the DHA and placebo groups, DHA did bring about noteworthy benefits. At 1 month, infants in the DHA group had a 26% shorter duration of cough and 30% shorter wheezing; however, they experienced a longer duration of rash.
Furthermore, by the time the infants reached 3 months, those whose mothers took DHA were ill for 14% less time overall. At 6 months, the DHA group showed significantly reduced durations of several illness indicators, although they did experience longer episodes of vomiting.
This study suggests that prenatal DHA not only seems to impact the occurrence of colds in children but may also play a role in the duration of symptoms over the first half-year of life.
Caregivers then reported on their infants’ health at 1, 3, and 6 months, sharing details about common illness symptoms. We found that DHA supplementation appeared to reduce the number of colds at one month and also seemed to lessen the duration of various cold symptoms in infants. Specifically, infants in the DHA group experienced fewer cold symptoms and had shorter durations of cough and wheezing.
While the overall occurrence of specific illness symptoms was similar between the DHA and placebo groups, DHA did bring about noteworthy benefits. At 1 month, infants in the DHA group had a 26% shorter duration of cough and 30% shorter wheezing; however, they experienced a longer duration of rash.
Furthermore, by the time the infants reached 3 months, those whose mothers took DHA were ill for 14% less time overall. At 6 months, the DHA group showed significantly reduced durations of several illness indicators, although they did experience longer episodes of vomiting.
This study suggests that prenatal DHA not only seems to impact the occurrence of colds in children but may also play a role in the duration of symptoms over the first half-year of life.
Read More
7
We examined the MITIGATE study, focusing on the effects of icosapent ethyl (IPE), a purified omega-3 fatty acid, in adults with cardiovascular disease at risk for viral upper respiratory infections.
With about 16,500 participants, this clinical trial compared IPE treatment against usual care. The goal was to see if IPE could lessen the severity and impact of viral infections over six months.
Unfortunately, there was no significant evidence found that IPE improved outcomes for upper respiratory infections in this group.
With about 16,500 participants, this clinical trial compared IPE treatment against usual care. The goal was to see if IPE could lessen the severity and impact of viral infections over six months.
Unfortunately, there was no significant evidence found that IPE improved outcomes for upper respiratory infections in this group.
Read More
User Reviews
USERS' SCORE
Good
Based on 10 Reviews
8.4
- All Reviews
- Positive Reviews
- Negative Reviews
9
Cold-free winter
6 people found this helpful
I have been taking this product for months and it's the first time I've never had that horrible 'fishy' taste after swallowing the pills. I’ve remained cold and flu free during winter in New Zealand, and my hair, nails, and skin appear fantastic. I highly recommend this product to anyone.
Read More
9
No flu experience
I've used this product all year and have not fallen ill with a cold or flu for the first time! It’s a fantastic product, has no fishy after-taste, and keeps my hair and nails looking fantastic. I highly recommend it to everyone.
Read More
9
Immune support
The ingredients are natural and good for health. Everyone should take it, as Omega-3 is beneficial for lowering cholesterol, improving hair growth, and providing anti-inflammatory properties. It strengthens the immune system and helps reduce the common cold's severity.
Read More
9
Joint pain relief
Omega-3 from Nordic Naturals supports heart, brain, and joint health. It has high levels of EPA and DHA, reduces inflammation, and has no unpleasant aftertaste. After taking it for several months, I've noticed improved skin condition and less joint pain, along with a better response to the common cold.
Read More
7.5
Fewer colds
1 people found this helpful
I give this Omega to my 8-year-old daughter. The taste is acceptable, and the lemon smell masks the oil well. It's gluten-free, which is essential for her intolerance. I've noticed fewer colds, and her skin is healthier. I trust this brand, having used other options for adults.
Read More
Frequently Asked Questions
9
Joint pain relief
Omega-3 from Nordic Naturals supports heart, brain, and joint health. It has high levels of EPA and DHA, reduces inflammation, and has no unpleasant aftertaste. After taking it for several months, I've noticed improved skin condition and less joint pain, along with a better response to the common cold.
7.5
Reduced colds
After considerable research, I selected Omega from Nordic for our family. We've been taking it every winter for years, resulting in fewer colds and improved hair quality. I confidently recommend it as we've tested its effectiveness in our family.
9
Cold-free winter
6 people found this helpful
I have been taking this product for months and it's the first time I've never had that horrible 'fishy' taste after swallowing the pills. I’ve remained cold and flu free during winter in New Zealand, and my hair, nails, and skin appear fantastic. I highly recommend this product to anyone.
9
No flu experience
I've used this product all year and have not fallen ill with a cold or flu for the first time! It’s a fantastic product, has no fishy after-taste, and keeps my hair and nails looking fantastic. I highly recommend it to everyone.
7.5
Fewer colds
1 people found this helpful
I give this Omega to my 8-year-old daughter. The taste is acceptable, and the lemon smell masks the oil well. It's gluten-free, which is essential for her intolerance. I've noticed fewer colds, and her skin is healthier. I trust this brand, having used other options for adults.
7.5
Easier colds
I bought this Omega-3 for my husband and myself for the autumn-winter season, and we found the common cold was much easier to withstand with this vitamin.
7.5
Healthy skin
I started giving Omega-3 to my child and noticed improvements in attention and concentration, along with fewer colds. His skin also looks healthier. The capsules have a neutral taste, and he takes them without issues. I recommend this supplement for children's health.
9
Immune support
The ingredients are natural and good for health. Everyone should take it, as Omega-3 is beneficial for lowering cholesterol, improving hair growth, and providing anti-inflammatory properties. It strengthens the immune system and helps reduce the common cold's severity.
7.5
Flu protection
These are the best Omega supplements, known for their quality. After taking this Omega, I noticed fewer colds. The capsules are large but easily swallowed, and I take it 1-2 times a day.
7
We examined the MITIGATE study, focusing on the effects of icosapent ethyl (IPE), a purified omega-3 fatty acid, in adults with cardiovascular disease at risk for viral upper respiratory infections.
With about 16,500 participants, this clinical trial compared IPE treatment against usual care. The goal was to see if IPE could lessen the severity and impact of viral infections over six months.
Unfortunately, there was no significant evidence found that IPE improved outcomes for upper respiratory infections in this group.
With about 16,500 participants, this clinical trial compared IPE treatment against usual care. The goal was to see if IPE could lessen the severity and impact of viral infections over six months.
Unfortunately, there was no significant evidence found that IPE improved outcomes for upper respiratory infections in this group.
8
We conducted a double-blind randomized controlled trial to understand how prenatal supplementation of docosahexaenoic acid (DHA) might influence infant health, particularly concerning the common cold. Pregnant women were given either a daily dose of 400 mg of DHA or a placebo starting at 18 to 22 weeks of gestation until childbirth.
Caregivers then reported on their infants’ health at 1, 3, and 6 months, sharing details about common illness symptoms. We found that DHA supplementation appeared to reduce the number of colds at one month and also seemed to lessen the duration of various cold symptoms in infants. Specifically, infants in the DHA group experienced fewer cold symptoms and had shorter durations of cough and wheezing.
While the overall occurrence of specific illness symptoms was similar between the DHA and placebo groups, DHA did bring about noteworthy benefits. At 1 month, infants in the DHA group had a 26% shorter duration of cough and 30% shorter wheezing; however, they experienced a longer duration of rash.
Furthermore, by the time the infants reached 3 months, those whose mothers took DHA were ill for 14% less time overall. At 6 months, the DHA group showed significantly reduced durations of several illness indicators, although they did experience longer episodes of vomiting.
This study suggests that prenatal DHA not only seems to impact the occurrence of colds in children but may also play a role in the duration of symptoms over the first half-year of life.
Caregivers then reported on their infants’ health at 1, 3, and 6 months, sharing details about common illness symptoms. We found that DHA supplementation appeared to reduce the number of colds at one month and also seemed to lessen the duration of various cold symptoms in infants. Specifically, infants in the DHA group experienced fewer cold symptoms and had shorter durations of cough and wheezing.
While the overall occurrence of specific illness symptoms was similar between the DHA and placebo groups, DHA did bring about noteworthy benefits. At 1 month, infants in the DHA group had a 26% shorter duration of cough and 30% shorter wheezing; however, they experienced a longer duration of rash.
Furthermore, by the time the infants reached 3 months, those whose mothers took DHA were ill for 14% less time overall. At 6 months, the DHA group showed significantly reduced durations of several illness indicators, although they did experience longer episodes of vomiting.
This study suggests that prenatal DHA not only seems to impact the occurrence of colds in children but may also play a role in the duration of symptoms over the first half-year of life.
8
We investigated whether feeding infants formula supplemented with docosahexaenoic acid (DHA) and arachidonic acid (ARA) could impact the development of allergies and respiratory illnesses until age three.
In a well-structured, randomized, double-blind study, we followed children who received either supplemented or nonsupplemented formulas during their first year of life. Our findings showed that those on the DHA/ARA formula had significantly lower chances of developing upper respiratory infections and common allergic diseases.
Notably, the DHA/ARA group experienced a delayed onset and reduced incidence of respiratory issues, indicating potential benefits of early nutrition on long-term health.
In a well-structured, randomized, double-blind study, we followed children who received either supplemented or nonsupplemented formulas during their first year of life. Our findings showed that those on the DHA/ARA formula had significantly lower chances of developing upper respiratory infections and common allergic diseases.
Notably, the DHA/ARA group experienced a delayed onset and reduced incidence of respiratory issues, indicating potential benefits of early nutrition on long-term health.
References
- Ambrosy AP, Malik UI, Thomas RC, Parikh RV, Tan TC, et al. Rationale and design of the pragmatic randomized trial of icosapent ethyl for high cardiovascular risk adults (MITIGATE). Am Heart J. 2021;235:54. doi:10.1016/j.ahj.2021.01.018
- Birch EE, Khoury JC, Berseth CL, Castañeda YS, Couch JM, et al. The impact of early nutrition on incidence of allergic manifestations and common respiratory illnesses in children. J Pediatr. 2010;156:902. doi:10.1016/j.jpeds.2010.01.002
- Imhoff-Kunsch B, Stein AD, Martorell R, Parra-Cabrera S, Romieu I, et al. Prenatal docosahexaenoic acid supplementation and infant morbidity: randomized controlled trial. Pediatrics. 2011;128:e505. doi:10.1542/peds.2010-1386
